Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal CarcinomaYuan Zhang, Jun Ma, Fang‐Yun Xie et al.|New England Journal of Medicine|2019Cited by 934
Single-cell transcriptomics reveals regulators underlying immune cell diversity and immune subtypes associated with prognosis in nasopharyngeal carcinomaYu‐Pei Chen, Jun Ma, Jianhua Yin et al.|Cell Research|2020Cited by 483
Long Noncoding RNA FAM225A Promotes Nasopharyngeal Carcinoma Tumorigenesis and Metastasis by Acting as ceRNA to Sponge miR-590-3p/miR-1275 and Upregulate ITGB3Zi‐Qi Zheng, Yingming Sun, Zhi‐Xuan Li et al.|Cancer Research|2019Cited by 423
Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trialYu‐Pei Chen, Jun Ma, Xu Liu et al.|The Lancet|2021Cited by 234
WTAP-mediated m6A modification of lncRNA DIAPH1-AS1 enhances its stability to facilitate nasopharyngeal carcinoma growth and metastasisZhi‐Xuan Li, Ying Sun, Zi‐Qi Zheng et al.|Cell Death and Differentiation|2022Cited by 173